MIR4659B: A Potential Drug Target and Biomarker (G100616372)
MIR4659B: A Potential Drug Target and Biomarker
Mir4659B, also known as ITGB3, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to investigate, and potential therapeutic approaches to target it have been proposed.
Mir4659B is a small non-coding RNA molecule that is expressed in various tissues and cells of the body. It is a part of the Intergenital Cell Transplantation (ICC) gene family, which is known for its role in the development and maintenance of tissues and organs. Mir4659B is a well- conserved gene that is expressed in many different organisms, including humans, and is highly conserved across different species, indicating its importance for fundamental cellular processes.
Mir4659B is a potential drug target because of its unique structure and function. Its small size and conserved nature make it a potential protein candidate that can be easily modified and targeted by small molecules or antibodies. Its expression in various tissues and cells also suggests that it may be a useful biomarker for disease diagnosis and monitoring.
One of the key features of Mir4659B is its expression in the placenta, which is a vital organ that plays a critical role in the development and maintenance of fetuses. The placenta is also a site of potential drug targeting, as many drugs that are effective in treating cancer and other diseases have been shown to be effective in the placenta. Therefore, targeting Mir4659B may be a promising approach to treating these diseases.
Mir4659B has also been shown to be involved in several diseases and disorders, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that Mir4659B is overexpressed in various types of cancer, including breast, lung, and ovarian cancer. This overexpression is associated with poor prognosis and therapeutic resistance, as well as increased inflammation and fibrosis. Therefore, targeting Mir4659B may be a promising approach to treating these diseases.
In addition to its potential therapeutic applications, Mir4659B is also a potential biomarker for disease diagnosis and monitoring. Its expression has been shown to be associated with several diseases and disorders, including cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, measuring the expression of Mir4659B may be a useful diagnostic tool for these diseases and a potential biomarker for disease monitoring.
In conclusion, Mir4659B is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and function make it an attractive target for researchers to investigate, and potential therapeutic approaches to target it have been proposed. Further research is needed to fully understand the role of Mir4659B in disease and to develop effective treatments.
Protein Name: MicroRNA 4659b
The "MIR4659B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4659B comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765
